BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21541688)

  • 21. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between Histogram Analysis Parameters Derived from DCE-MRI and Histopathological Features including Expression of EGFR, p16, VEGF, Hif1-alpha, and p53 in HNSCC.
    Meyer HJ; Leifels L; Hamerla G; Höhn AK; Surov A
    Contrast Media Mol Imaging; 2019; 2019():5081909. PubMed ID: 30718984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.
    Jain R; Narang J; Griffith B; Bagher-Ebadian H; Scarpace L; Mikkelsen T; Littenberg B; Schultz LR
    Acad Radiol; 2013 Apr; 20(4):478-85. PubMed ID: 23498990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading.
    Server A; Graff BA; Orheim TE; Schellhorn T; Josefsen R; Gadmar ØB; Nakstad PH
    Neuroradiology; 2011 Jun; 53(6):435-47. PubMed ID: 20857284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
    Young R; Babb J; Law M; Pollack E; Johnson G
    J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging.
    Zhu XP; Li KL; Kamaly-Asl ID; Checkley DR; Tessier JJ; Waterton JC; Jackson A
    J Magn Reson Imaging; 2000 Jun; 11(6):575-85. PubMed ID: 10862055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of perfusion MRI in differentiating low-grade and high-grade gliomas: advanced MRI in glioma, A Siriraj project.
    Direksunthorn T; Chawalparit O; Sangruchi T; Witthiwej T; Tritrakarn SO; Piyapittayanan S; Charnchaowanish P; Pornpunyawut P; Sathornsumetee S
    J Med Assoc Thai; 2013 Sep; 96(9):1183-90. PubMed ID: 24163995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Dynamic Contrast-Enhanced Perfusion Magnetic Resonance Imaging in Grading of Pediatric Brain Tumors on 3T.
    Gupta PK; Saini J; Sahoo P; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Pediatr Neurosurg; 2017; 52(5):298-305. PubMed ID: 28848203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of artery input function on dynamic contrast-enhanced MRI for determining grades of gliomas.
    Jia L; Wu X; Wan Q; Wan L; Jia W; Zhang N
    Br J Radiol; 2021 Mar; 94(1119):20200699. PubMed ID: 33332981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
    Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
    J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
    Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
    AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas.
    Law M; Young R; Babb J; Pollack E; Johnson G
    AJNR Am J Neuroradiol; 2007 Apr; 28(4):761-6. PubMed ID: 17416835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histogram analysis of T2*-based pharmacokinetic imaging in cerebral glioma grading.
    Liu HS; Chiang SW; Chung HW; Tsai PH; Hsu FT; Cho NY; Wang CY; Chou MC; Chen CY
    Comput Methods Programs Biomed; 2018 Mar; 155():19-27. PubMed ID: 29512499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
    Sentürk S; Oğuz KK; Cila A
    Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Can Differentiate Between Atypical Cartilaginous Tumors and High-Grade Chondrosarcoma: Correlation With Histological Vessel Characteristics.
    Jin B; Yang J; Zhen J; Xu Y; Wang C; Jing Q; Shang Y
    J Comput Assist Tomogr; 2024 Jan-Feb 01; 48(1):123-128. PubMed ID: 37558644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AQP-4 in peritumoral edematous tissue is correlated with the degree of glioma and with expression of VEGF and HIF-alpha.
    Mou K; Chen M; Mao Q; Wang P; Ni R; Xia X; Liu Y
    J Neurooncol; 2010 Dec; 100(3):375-83. PubMed ID: 20467785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results.
    Larsson C; Kleppestø M; Rasmussen I; Salo R; Vardal J; Brandal P; Bjørnerud A
    J Magn Reson Imaging; 2013 Apr; 37(4):818-29. PubMed ID: 23086710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative Grading of Glioma Using Dynamic Susceptibility Contrast MRI: Relative Cerebral Blood Volume Analysis of Intra-tumoural and Peri-tumoural Tissue.
    Soliman RK; Gamal SA; Essa AA; Othman MH
    Clin Neurol Neurosurg; 2018 Apr; 167():86-92. PubMed ID: 29471287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.